|
|
The New Developments in Lung and Head & Neck Cancers symposium is to update oncologists and thoracic surgeons on the recent advances. The recent developments include anti-EGFR, antiangiogenic, and treatment of lung cancer will be discussed in the symposium. In addition the New Developments in Lung and Head & Neck Cancers symposium includes frontline treatment and efforts to individualize treatment. Sessions for optimizing lung cancer will also be presented by the speakers in the symposium. In the symposia new approaches to improve systemic therapy for head and neck cancer through the use of predictive markers, targeted agents, and induction regimens will be laid emphasis on. The symposium also includes one on one interview with experts and speakers.
Visitor Profile
The targeted audience for the New Developments in Lung and Head & Neck Cancers are as follows:
- Thoracic Surgeons
- Radiation Oncologists
- Medical Oncologists
- Nurses
- Pharmacist
- Physician
- Medical Students
- Media Agencies
- General public
- Medical Institutions
Organizer
Physicians' Education Resource
